Literature DB >> 7669738

Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers.

M L Yaremko1, W M Recant, C A Westbrook.   

Abstract

Loss of heterozygosity (LOH) from the short arm of chromosome 8 (8p) is common to many human carcinomas, including those of the colon and prostate. It localizes to two discrete regions, 8p21 and 8p22. This suggests the presence of at least two tumor suppressor genes (TSGs) on this chromosome arm. Human breast cancers show consistent 8p deletions in cytogenetic studies, chromosome 8 aneusomy and isochromosome 8q, indicating that the relevant gene(s) may play a role, but the results of molecular analyses of chromosome 8 in breast cancer have been variable. We present here data for 8p LOH in an unselected series of human breast cancers with the use of three CA-repeat markers that showed high rates of LOH in other tumors. All cases were informative for at least one marker, and LOH was seen in 11 of 20 cases (55%). LOH was more frequent for the 8p22 markers D8S254 and D8S133 than for NEFL in 8p21. Regional metastases of the tumors showed allele profiles identical to those of their primaries regardless of whether there was LOH or retention of alleles. One case of microsatellite instability (RER+) was seen. LOH did not correlate with receptor status, ploidy, percentage of cells in S phase, or tumor size: We observed LOH at equal rates in small (< 2 cm) and in larger (> 2 cm) tumors. The data suggest that LOH from 8p is frequent in human breast cancers and that loss of the putative 8p TSG may be an important event in early stage breast cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669738     DOI: 10.1002/gcc.2870130308

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization.

Authors:  Yuxia Gao; Yun Niu; Xiaowei Wang; Li Wei; Song Lu
Journal:  J Mol Med (Berl)       Date:  2008-10-21       Impact factor: 4.599

3.  Common genetic variants in NEFL influence gene expression and neuroblastoma risk.

Authors:  Mario Capasso; Sharon Diskin; Flora Cimmino; Giovanni Acierno; Francesca Totaro; Giuseppe Petrosino; Lucia Pezone; Maura Diamond; Lee McDaniel; Hakon Hakonarson; Achille Iolascon; Marcella Devoto; John M Maris
Journal:  Cancer Res       Date:  2014-10-13       Impact factor: 12.701

4.  Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.

Authors:  B I Sigbjörnsdottir; G Ragnarsson; B A Agnarsson; C Huiping; R B Barkardottir; V Egilsson; S Ingvarsson
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

5.  The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.

Authors:  H Ishii; R Baffa; S I Numata; Y Murakumo; S Rattan; H Inoue; M Mori; V Fidanza; H Alder; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  8p deletion is strongly linked to poor prognosis in breast cancer.

Authors:  P Lebok; A Mittenzwei; M Kluth; C Özden; B Taskin; K Hussein; K Möller; A Hartmann; A Lebeau; I Witzel; S Mahner; L Wölber; F Jänicke; S Geist; P Paluchowski; C Wilke; U Heilenkötter; R Simon; G Sauter; L Terracciano; R Krech; A von der Assen; V Müller; E Burandt
Journal:  Cancer Biol Ther       Date:  2015-05-11       Impact factor: 4.742

7.  Allelic loss of chromosomal arm 8p in breast cancer progression.

Authors:  R Anbazhagan; H Fujii; E Gabrielson
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

Review 8.  Molecular biology of prostate cancer.

Authors:  X B Shi; P H Gumerlock; R W deVere White
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

9.  An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer.

Authors:  Raj Chari; Bradley P Coe; Emily A Vucic; William W Lockwood; Wan L Lam
Journal:  BMC Syst Biol       Date:  2010-05-17

10.  Immunomagnetic separation can enrich fixed solid tumors for epithelial cells.

Authors:  M L Yaremko; P R Kelemen; C Kutza; D Barker; C A Westbrook
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.